Literature DB >> 33071066

Expiratory dysfunction in young dogs with golden retriever muscular dystrophy.

Eleanor C Hawkins1, Amanda K Bettis2, Joe N Kornegay2.   

Abstract

Respiratory disease is a leading cause of morbidity in people with Duchenne muscular dystrophy and also occurs in the golden retriever muscular dystrophy (GRMD) model. We have previously shown that adult GRMD dogs have elevated expiratory flow as measured non-invasively during tidal breathing. This abnormality likely results from increased chest and diaphragmatic recoil associated with fibrosis and remodeling. Treatments must reverse pathologic effects on the diaphragm and other respiratory muscles to maximally reduce disease morbidity and mortality. Here, we extended our work in adults to younger GRMD dogs to define parameters that would be helpful in preclinical trials. Tidal breathing spirometry and respiratory inductance plethysmography were performed in GRMD dogs at approximately 3 and 6 months of age, corresponding to approximately 5-10 years in DMD, when clinical trials are often conducted. Expiratory flows were markedly elevated in GRMD versus normal dogs at 6 months. Values increased in GRMD dogs between 3 and 6 months, providing a 3-month window to assess treatment efficacy. These changes in breathing mechanics have not been previously identified at such an early age. Expiratory flow measured during tidal breathing of unsedated young GRMD dogs could be a valuable marker of respiratory mechanics during preclinical trials.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Duchenne muscular dystrophy (DMD); Golden retriever muscular dystrophy (GRMD); Peak expiratory flow; Pulmonary function test; Respiratory inductance plethysmography; Spirometry

Year:  2020        PMID: 33071066      PMCID: PMC7680419          DOI: 10.1016/j.nmd.2020.09.027

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  29 in total

1.  Analysis of tidal breathing flow volume loop in dogs with tracheal masses.

Authors:  Kk Adamama-Moraitou; D Pardali; N N Prassinos; L G Papazoglou; D Makris; K I Gourgoulianis; N Papaioannou; T S Rallis
Journal:  Aust Vet J       Date:  2010-09       Impact factor: 1.281

Review 2.  Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy.

Authors:  D Gozal
Journal:  Pediatr Pulmonol       Date:  2000-02

3.  Regulation of end-expiratory lung volume during exercise.

Authors:  K G Henke; M Sharratt; D Pegelow; J A Dempsey
Journal:  J Appl Physiol (1985)       Date:  1988-01

4.  Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs.

Authors:  R J Bartlett; N J Winand; S L Secore; J T Singer; S Fletcher; S Wilton; D J Bogan; J R Metcalf-Bogan; W T Bartlett; J M Howell; B J Cooper; J N Kornegay
Journal:  Am J Vet Res       Date:  1996-05       Impact factor: 1.156

5.  Muscular dystrophy in a litter of golden retriever dogs.

Authors:  J N Kornegay; S M Tuler; D M Miller; D C Levesque
Journal:  Muscle Nerve       Date:  1988-10       Impact factor: 3.217

6.  Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Robert W Grange
Journal:  Methods Mol Biol       Date:  2011

7.  Contraction force generated by tarsal joint flexion and extension in dogs with golden retriever muscular dystrophy.

Authors:  J N Kornegay; D J Bogan; J R Bogan; M K Childers; D D Cundiff; G F Petroski; R O Schueler
Journal:  J Neurol Sci       Date:  1999-07-01       Impact factor: 3.181

8.  Morphological and ultrastructural evaluation of the golden retriever muscular dystrophy trachea, lungs, and diaphragm muscle.

Authors:  Thais Borges Lessa; Dilayla Kelly de Abreu; Márcio Nogueira Rodrigues; Marina Pandolphi Brólio; Maria Angélica Miglino; Carlos Eduardo Ambrósio
Journal:  Microsc Res Tech       Date:  2014-08-01       Impact factor: 2.769

9.  Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.

Authors:  M H Brooke; G M Fenichel; R C Griggs; J R Mendell; R Moxley; J P Miller; M A Province
Journal:  Muscle Nerve       Date:  1983-02       Impact factor: 3.217

Review 10.  The golden retriever model of Duchenne muscular dystrophy.

Authors:  Joe N Kornegay
Journal:  Skelet Muscle       Date:  2017-05-19       Impact factor: 4.912

View more
  3 in total

Review 1.  Breathing in Duchenne muscular dystrophy: translation to therapy.

Authors:  Doreen Z Mhandire; David P Burns; Angela L Roger; Ken D O'Halloran; Mai K ElMallah
Journal:  J Physiol       Date:  2022-06-24       Impact factor: 6.228

2.  Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.

Authors:  Maria Siemionow; Paulina Langa; Sonia Brodowska; Katarzyna Kozlowska; Kristina Zalants; Katarzyna Budzynska; Ahlke Heydemann
Journal:  Stem Cell Rev Rep       Date:  2022-05-19       Impact factor: 6.692

3.  Non-Invasive Optical Motion Tracking Allows Monitoring of Respiratory Dynamics in Dystrophin-Deficient Mice.

Authors:  Angelika Svetlove; Jonas Albers; Swen Hülsmann; Marietta Andrea Markus; Jana Zschüntzsch; Frauke Alves; Christian Dullin
Journal:  Cells       Date:  2022-03-07       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.